Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant Tolerance”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Testing effectiveness (Phase 2)UnknownNCT01198314
What this trial is testing

Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients

Who this might be right for
Liver Transplantation
The Catholic University of Korea 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT00319657
What this trial is testing

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

Who this might be right for
Immune Tolerance
Stanford University 15
Testing effectiveness (Phase 2)Study completedNCT00801632
What this trial is testing

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

Who this might be right for
Kidney TransplantationKidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 5
Early research (Phase 1)Active Not RecruitingNCT05806749
What this trial is testing

Immunological Tolerance in Patients With Mismatched Kidney Transplants

Who this might be right for
End Stage Kidney DiseaseImmunological ToleranceKidney Transplant Failure and Rejection+1 more
University of California, Los Angeles 16
Not applicableUnknownNCT03373526
What this trial is testing

Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation

Who this might be right for
LymphomaMyelomaLeukemia+1 more
Daniel Godoy Martinez 50
Post-approval studies (Phase 4)Ended earlyNCT02949492
What this trial is testing

Low-dose IL-2 for Treg Expansion and Tolerance (LITE)

Who this might be right for
TransplantationLiver Diseases
King's College London 6
Not applicableStudy completedNCT00002285
What this trial is testing

Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS

Who this might be right for
HIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT01629979
What this trial is testing

Epidermal Cell Transplantation in Vitiligo Skin

Who this might be right for
VITILIGO
Centre Hospitalier Universitaire de Nice 23
Not applicableStudy completedNCT00615225
What this trial is testing

Brain Death: Inflammatory Response, Apoptosis, and Endotoxin Tolerance

Who this might be right for
Brain Death
Delafontaine Hospital
Post-approval studies (Phase 4)Study completedNCT02105155
What this trial is testing

Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation

Who this might be right for
Immunosuppression After Liver Transplantation
Assistance Publique - Hôpitaux de Paris 90
Testing effectiveness (Phase 2)Looking for participantsNCT05365672
What this trial is testing

Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplantation
TolerogenixX GmbH 126
Testing effectiveness (Phase 2)Study completedNCT00105235
What this trial is testing

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

Who this might be right for
Liver DiseaseLiver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableUnknownNCT02319226
What this trial is testing

Toward Immune Biomarkers for Tolerance and GvHD in Humans

Who this might be right for
Bone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Study completedNCT01294254
What this trial is testing

Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites

Who this might be right for
Accelerating the Epithelialization of Split Thickness Skin Graft
Birken AG 24
Testing effectiveness (Phase 2)Study completedNCT00076570
What this trial is testing

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31
Not applicableNo Longer AvailableNCT02051673
What this trial is testing

Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)

Who this might be right for
Renal Failure
Talaris Therapeutics Inc.
Post-approval studies (Phase 4)Study completedNCT00740363
What this trial is testing

Sitagliptin in Renal Transplant Recipients

Who this might be right for
Glucose Intolerance
University of Oslo School of Pharmacy 25
Testing effectiveness (Phase 2)WithdrawnNCT03606746
What this trial is testing

Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

Who this might be right for
Kidney Transplant Rejection
Medeor Therapeutics, Inc.
Early research (Phase 1)Looking for participantsNCT04180059
What this trial is testing

Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Haematologic Disease
Nantes University Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT00436722
What this trial is testing

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

Who this might be right for
Liver Diseases
Hospital Clinic of Barcelona 72
Load More Results